Bridget E. Bunner

Array ( [id] => 5694790 [patent_doc_number] => 20060154937 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-13 [patent_title] => 'Novel farnesyl protein transferase inhibitors and their use to treat cancer' [patent_app_type] => utility [patent_app_number] => 11/301308 [patent_app_country] => US [patent_app_date] => 2005-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34179 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0154/20060154937.pdf [firstpage_image] =>[orig_patent_app_number] => 11301308 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6431909 [patent_doc_number] => 20100152174 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'MACROCYCLIC QUINAZOLE DERIVATIVES AND THEIR USE AS MTKI' [patent_app_type] => utility [patent_app_number] => 11/720693 [patent_app_country] => US [patent_app_date] => 2005-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26493 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20100152174.pdf [firstpage_image] =>[orig_patent_app_number] => 11720693 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5656533 [patent_doc_number] => 20060142269 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'New compounds' [patent_app_type] => utility [patent_app_number] => 11/296928 [patent_app_country] => US [patent_app_date] => 2005-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15519 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20060142269.pdf [firstpage_image] =>[orig_patent_app_number] => 11296928 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5844477 [patent_doc_number] => 20060122189 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition' [patent_app_type] => utility [patent_app_number] => 11/294602 [patent_app_country] => US [patent_app_date] => 2005-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16276 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20060122189.pdf [firstpage_image] =>[orig_patent_app_number] => 11294602 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5844477 [patent_doc_number] => 20060122189 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition' [patent_app_type] => utility [patent_app_number] => 11/294602 [patent_app_country] => US [patent_app_date] => 2005-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16276 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20060122189.pdf [firstpage_image] =>[orig_patent_app_number] => 11294602 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5835425 [patent_doc_number] => 20060247256 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition' [patent_app_type] => utility [patent_app_number] => 11/294615 [patent_app_country] => US [patent_app_date] => 2005-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11894 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20060247256.pdf [firstpage_image] =>[orig_patent_app_number] => 11294615 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5835425 [patent_doc_number] => 20060247256 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition' [patent_app_type] => utility [patent_app_number] => 11/294615 [patent_app_country] => US [patent_app_date] => 2005-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11894 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20060247256.pdf [firstpage_image] =>[orig_patent_app_number] => 11294615 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8797071 [patent_doc_number] => 08435938 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-07 [patent_title] => 'Pure vancomycin hydrochloride' [patent_app_type] => utility [patent_app_number] => 11/720893 [patent_app_country] => US [patent_app_date] => 2005-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3069 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 151 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11720893 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5678390 [patent_doc_number] => 20060183746 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-17 [patent_title] => 'Certain imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of Bruton\'s tyrosine kinase by such compounds' [patent_app_type] => utility [patent_app_number] => 11/292300 [patent_app_country] => US [patent_app_date] => 2005-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 85025 [patent_no_of_claims] => 80 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20060183746.pdf [firstpage_image] =>[orig_patent_app_number] => 11292300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 131833 [patent_doc_number] => 07700597 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-20 [patent_title] => 'Substituted piperazines as CB1 antagonists' [patent_app_type] => utility [patent_app_number] => 11/292264 [patent_app_country] => US [patent_app_date] => 2005-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 56634 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/700/07700597.pdf [firstpage_image] =>[orig_patent_app_number] => 11292264 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5422993 [patent_doc_number] => 20090149448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-11 [patent_title] => 'Phenoxyacetic Acid Derivatives Useful for Treating Respiratory Diseases' [patent_app_type] => utility [patent_app_number] => 11/719832 [patent_app_country] => US [patent_app_date] => 2005-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35716 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0149/20090149448.pdf [firstpage_image] =>[orig_patent_app_number] => 11719832 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5844563 [patent_doc_number] => 20060122222 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Heterocycle substituted carboxylic acids' [patent_app_type] => utility [patent_app_number] => 11/282390 [patent_app_country] => US [patent_app_date] => 2005-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31854 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20060122222.pdf [firstpage_image] =>[orig_patent_app_number] => 11282390 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5564700 [patent_doc_number] => 20090137553 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'Thiazepine Oxazolidinones as Antibacterial Agents' [patent_app_type] => utility [patent_app_number] => 11/577997 [patent_app_country] => US [patent_app_date] => 2005-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11243 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20090137553.pdf [firstpage_image] =>[orig_patent_app_number] => 11577997 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4860452 [patent_doc_number] => 20080269302 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'Macrocyclic Tertiary Amine Beta-Secretase Inhibitors for the Treatment of Alzheimer\'s Disease' [patent_app_type] => utility [patent_app_number] => 11/667913 [patent_app_country] => US [patent_app_date] => 2005-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27554 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20080269302.pdf [firstpage_image] =>[orig_patent_app_number] => 11667913 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5673012 [patent_doc_number] => 20060178367 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-10 [patent_title] => 'Certain imidazo[1,2-a]pyrazin-8-ylamines, method of making, and method of use thereof' [patent_app_type] => utility [patent_app_number] => 11/270837 [patent_app_country] => US [patent_app_date] => 2005-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28230 [patent_no_of_claims] => 92 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20060178367.pdf [firstpage_image] =>[orig_patent_app_number] => 11270837 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5777388 [patent_doc_number] => 20060106028 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-18 [patent_title] => 'Polycyclic aromatics and derivatives thereof and processes for their preparation' [patent_app_type] => utility [patent_app_number] => 11/268610 [patent_app_country] => US [patent_app_date] => 2005-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 23870 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20060106028.pdf [firstpage_image] =>[orig_patent_app_number] => 11268610 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5866301 [patent_doc_number] => 20060100432 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-11 [patent_title] => 'Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione' [patent_app_type] => utility [patent_app_number] => 11/267440 [patent_app_country] => US [patent_app_date] => 2005-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 7288 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20060100432.pdf [firstpage_image] =>[orig_patent_app_number] => 11267440 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 23952 [patent_doc_number] => 07795247 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-14 [patent_title] => 'Tetracyclic indole derivatives as antiviral agents' [patent_app_type] => utility [patent_app_number] => 11/258445 [patent_app_country] => US [patent_app_date] => 2005-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36692 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/795/07795247.pdf [firstpage_image] =>[orig_patent_app_number] => 11258445 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5777389 [patent_doc_number] => 20060106029 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-18 [patent_title] => 'Novel aminopyridine derivatives having aurora a selective inhibitory action' [patent_app_type] => utility [patent_app_number] => 11/258447 [patent_app_country] => US [patent_app_date] => 2005-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52721 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20060106029.pdf [firstpage_image] =>[orig_patent_app_number] => 11258447 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 585771 [patent_doc_number] => 07446210 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-04 [patent_title] => 'Factor Xa compounds' [patent_app_type] => utility [patent_app_number] => 11/257208 [patent_app_country] => US [patent_app_date] => 2005-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28124 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/446/07446210.pdf [firstpage_image] =>[orig_patent_app_number] => 11257208 [rel_patent_id] =>[rel_patent_doc_number] =>)